Add like
Add dislike
Add to saved papers

Lenticular opacities in carriers of Lowe's syndrome.

Ophthalmology 1986 August
Eleven possible and five obligate carriers of Lowe's syndrome from the same pedigree were examined for lens opacities. All of the obligate carriers and 4 of the 11 at risk had lens abnormalities. The lenticular abnormalities consisted of cortical dots of various shapes that increased in number with the age of the carriers in older obligate carriers, subcapsular plaques were common. Because the syndrome is X linked, such lens changes are explainable by the Lyon's hypothesis. When the number of opacities seen in these subjects were compared to those seen in 100 normal control females 10 to 20 years of age, cataractagenic cases such as diabetes, Down's and fetal nuclear opacities excluded, four probable carriers were identified among the eleven possible carriers in the pedigree. These subjects had significantly greater numbers of opacities, similar to those seen in obligate carriers, compared to controls. We conclude that progressive lens changes are present in carriers of Lowe's syndrome and that young carrier females can be identified reliably when they are compared to age-matched controls by modifying the grading system of Brown and Gardner.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app